Bayer Total Long Term Liabilities 2010-2024 | BAYRY

Bayer total long term liabilities for the quarter ending September 30, 2024 were $56.304B, a 2.21% increase year-over-year.

  • Bayer total long term liabilities for 2023 were $58.145B, a 8.49% increase from 2022.
  • Bayer total long term liabilities for 2022 were $53.593B, a 21.45% decline from 2021.
  • Bayer total long term liabilities for 2021 were $68.229B, a 20.38% increase from 2020.

Bayer Total Long Term Liabilities 2010-2024 | BAYRY

  • Bayer total long term liabilities for 2023 were $58.145B, a 8.49% increase from 2022.
  • Bayer total long term liabilities for 2022 were $53.593B, a 21.45% decline from 2021.
  • Bayer total long term liabilities for 2021 were $68.229B, a 20.38% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B